Certainly! Here is a structured supplement and improvement of the product information for the Anti-Human Fibrin Antibody (59D8):

---

Product Name:
Anti-Human Fibrin Antibody (59D8)

Storage:
- Store at -20°C for long-term storage.
- For short-term use, the antibody can be stored at 4°C.
- Avoid repeated freeze-thaw cycles to maintain antibody integrity.
- Ensure the storage container is tightly sealed to prevent contamination.

Product Description:
The Anti-Human Fibrin Antibody (59D8) is a monoclonal antibody specifically developed to recognize and bind to human fibrin. Fibrin is a fibrous protein involved in the clotting process, forming a mesh that traps blood cells and platelets to create a stable clot. The 59D8 antibody is highly specific for fibrin, making it an essential tool for research and diagnostic applications related to hemostasis and thrombosis.

Key Features:
- Specificity: High specificity for human fibrin, ensuring accurate detection in various assays.
- Monoclonal: Provides consistent performance across different applications due to its monoclonal nature.
- Purity: Manufactured with high purity standards to minimize non-specific binding.
- Versatility: Suitable for use in ELISA, Western blotting, immunohistochemistry, and other immunoassays.

What's Included:
- Anti-Human Fibrin Antibody (59D8) vial, typically available in concentrations of 0.5 mg/mL or 1 mg/mL.
- A datasheet with product information, recommended protocols, and usage guidelines.
- Certificate of analysis to verify product quality and performance.

Applications:
- Research: Ideal for studying clot formation and dissolution processes, as well as investigating disorders related to coagulation such as hemophilia and thrombosis.
- Diagnostics: Useful in diagnostic assays for detecting abnormal fibrin levels in blood samples, aiding in the diagnosis of clotting disorders.
- Histological Studies: Applicable in immunohistochemistry to examine fibrin deposition in tissue samples, providing insights into pathological conditions such as stroke, myocardial infarction, and cancer.
- Drug Development: Facilitates the evaluation of anticoagulant drugs and their effects on fibrin formation and stability.

---

This structured information provides a comprehensive overview of the Anti-Human Fibrin Antibody (59D8), enhancing its utility and accessibility for potential users in various fields of research and diagnostics.